AdventHealth — Orlando, Florida

Public research footprint of AdventHealth, compiled from the ClinicalTrials.gov public registry.

630

Registered studies

338

Active

136

Recruiting now

218

Completed

Stopped or withdrawn

Most-studied conditions

Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Lung Non-Small Cell Squamous Carcinoma · Metastatic Bladder Large Cell Neuroendocrine Carcinoma · Metastatic Non-Cutaneous Melanoma

Recently updated registry entries

NCT06952504 — A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… (Recruiting)
NCT05142696 — A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With… (Active Not Recruiting)
NCT05987241 — Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at AdventHealth?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.